RYAN MYERS: Open Payments
NPI 1942700182 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,419 in 78 payments from 15 companies in 2025. Trend: 2023 $725 · 2024 $1,148 · 2025 $1,419
Food & beverage: $1,419
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $385 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $218 |
| Alkermes, Inc. | 13 | $165 |
| Axsome Therapeutics, Inc. | 4 | $157 |
| Vanda Pharmaceuticals Inc. | 5 | $102 |
| Supernus Pharmaceuticals, Inc. | 1 | $66 |
| E.R. Squibb & Sons, L.L.C. | 2 | $64 |
| Noven Therapeutics, LLC | 2 | $44 |
| Tris Pharma Inc | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, Auvelity, FANAPT, Qelbree, COBENFY, Xelstrym.
Industry payments across FL — which companies pay providers there.
